Navigation Links
EPIX Pharmaceuticals, Inc. Assigns all Its Assets to Joseph F. Finn, Jr., C.P.A. for the Benefit of Its Creditors
Date:7/22/2009

WELLESLEY HILLS, Mass., July 22 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn"), announced today that assets of EPIX Pharmaceuticals, Inc. ("EPIX") have been assigned to him for the benefit of EPIX's creditors.

EPIX's products and services focus on the discovery and development of novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform. The company has a pipeline of internally-discovered drug candidates currently in clinical development to treat diseases of the central nervous system and lung conditions. In addition, EPIX has several programs related to its MRI imaging business, including a commercial MRI imaging drug in Europe, (MS-325), formerly marketed as Vasorist(R), gadofosveset trisodium, by Bayer Schering Pharma.) EPIX also has collaborations with several leading pharmaceutical and research foundations.

The intellectual property, regulatory dossier, fixed assets and clinical inventory will be sold at auction, the time and date of which will be announced within a week.

Persons interested in bidding must sign a Confidentiality Disclosure Agreement ("CDA") obtained from Finn's Office - jffinnjr@earthlink.net or 781-237-8840. They will then receive a bid package.

About Joseph F. Finn, Jr., C.P.A.

Joseph F. Finn, Jr., C.P.A. is the founding partner of the firm, Finn, Warnke & Gayton, Certified Public Accountants of Wellesley Hills, Massachusetts. He works primarily in the area of management consulting for distressed enterprises, bankruptcy accounting and related matters, such as assignee for the benefit of creditors and liquidating agent for a corporation. He has been involved in a number of loan workouts and ba
'/>"/>

SOURCE Joseph F. Finn, Jr., C.P.A.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Biostar Pharmaceuticals, Inc. Receives Government Approvals for Three New Products
2. Solvay Pharmaceuticals, Inc. Announces Commercial Availability of CREON(R) (Pancrelipase) Delayed-Release Capsules
3. Biostar Pharmaceuticals, Inc. Commences the Full Implementation of New Rural Cooperative Supply Network Plan
4. Lotus Pharmaceuticals, Inc. Again Awarded GSP Certification
5. Biostar Pharmaceuticals, Inc. Begins Construction of Raw Material Processing Facility of the Herbal Plantation Base
6. Atlantic Pharmaceuticals, Inc. Announces Completion of Successful Pre-IND Meeting with FDA for Abuse Deterrent Narcotic
7. Lotus Pharmaceuticals, Inc. to Exhibit at the 2009 International Conference for Bioeconomy
8. Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals, Inc. and Second Quarter 2009 Financial Results
9. Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
10. Metastorm Customer, Wyeth Pharmaceuticals, Wins CIO 100 Award for BPM Project
11. Anadys Pharmaceuticals, Inc. Announces Pricing of Common Stock and Warrant Offering

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... Innovative medical apparel compan...ce , San Clemente, Calif.... of breakthrough medical apparel, today announced ...splay at Medica 2009, a leading international trad..., Germany. Medelita inaugurates its men,s collecti...
(Date:11/21/2009)... New Haven Dental Group merges the...of Branford, CT. , (PRWEB... comprised of partners Dr. David Gibson, Dr. Dean ...ter has just merged their growing practice with th... ,When Dr. Pickman decided he wanted to retire fro...
(Date:11/20/2009)..., PRINCETON, NJ, Nov. 20 /PRNewswire-FirstCall/ -...t a Special Meeting of Shareholders will be held o...eting is to consider approval of two special resol... and authorize the sale of all or substantially al...erms provided for in the asset purchase agreement ...
(Date:11/20/2009)..., QUINCY, Mass., Nov. 20 Following...ket Company removed from sale Shedd,s Country Croc...and Shedd,s Country Crock ® Side Dishes DELUX...llergen. ,, The following code dates and UPCs ...Side Dishes DELUXE Cheddar Broccoli Rice 21 oz, UP...
(Date:11/20/2009)..., CHICAGO, Nov. 20 The ...U.S. Food and Drug Administration (FDA) to establi... chemicals. ,, Citing concern about the safety... without the benefit of professional consultation ...that the application of chemically based tooth whi...
Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:New Haven Dental Group Expands Their Vision 2Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2
...tries to combat the bird flu menace which threaten...egion. The plan, to be finalized in two weeks, // ...of which have already been affected by bird flu ou...ng on Early Response to Potential Influenza Pandem...
...theast Asia seems to have shifted its infection to...e city of Van in eastern Turkey has experienced th...the virus from poultry. The people infected with t...is a beautiful place and attracts lot of tourists ...
... to deformed babies, according to study published ...oking half a packet of cigarettes // a day may rai...ts may be felt even before the woman is aware that...Benjamin Chang, M.D., pediatric plastic and recons...
...low for fighting bird flu on Friday, and the World...ht the pandemic on a global scale.// Most of th...ic region, followed by Europe and Central Asia, an...n North America. The European Union has already...
...g blood sugar, according to a new research study. ...d at the molecules in the brain // which respond t...reatment of the condition. The brain has a signifi...re it was found that side effects like putting on ...
...haemagglutinin protein of the bird flu virus. Haem... the virus to the host and the variability // and ...volution of new strains of the virus, if a person ...s of joining of two fragments from two virus leadi...
Other Medicine News:Health News:Countries Step up Battle Against Bird Flu 2Health News:Countries Step up Battle Against Bird Flu 3
(Date:11/19/2009)...an, Nov. 19 /PRNewswire-Asia/ -- ScinoPharm, a lea...edients (APIs), announced that its,Tainan facility...tion from,SafeBridge(R) Consultants, Inc. The Cert...ficiency in the safe handling of potent active,pha...cific laboratories and,production areas used for t...
(Date:11/19/2009)..., Nov. 19 The D e al ...f its Most Admired Corporate Dealmakers for the se...as its Most Admired Dealmaker in pharma/biotech fo... and divestitures since January 2006. ,, Over t...ortfolio with a focus on high-growth, innovation-d...
(Date:11/19/2009)...ational Internet Week of Action ,, SILVER SPRI...S. Food and Drug Administration today completed a ...d the International Internet Week of Action (IIWA)...al products. ,, (Logo: http://www.newscom.com/...ffort, the FDA,s Office of Criminal Investigations...
Breaking Medicine Technology:ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2CareFusion Launches New Brand Establishing Itself as an Industry Leader in Helping Hospitals Improve Patient Care and Safety 50517 1CareFusion Launches New Brand Establishing Itself as an Industry Leader in Helping Hospitals Improve Patient Care and Safety 50517 2CareFusion Launches New Brand Establishing Itself as an Industry Leader in Helping Hospitals Improve Patient Care and Safety 50517 3BioMarin to Host Second Quarter 2009 Financial Results Conference Call and Webcast on Thursday July 30 at 5 3A00 p m ET 2823 3A00 CET 29 50515 1BioMarin to Host Second Quarter 2009 Financial Results Conference Call and Webcast on Thursday July 30 at 5 3A00 p m ET 2823 3A00 CET 29 50515 2Air Force Chief Master Sergeant Rod McKinley 28U S Air Force Retired 29 Joins MicroTech as Vice President of Strategic Partnerships 12870 1Air Force Chief Master Sergeant Rod McKinley 28U S Air Force Retired 29 Joins MicroTech as Vice President of Strategic Partnerships 12870 2Air Force Chief Master Sergeant Rod McKinley 28U S Air Force Retired 29 Joins MicroTech as Vice President of Strategic Partnerships 12870 3
...um: The Takeda Oncology,Company today reported upd...ed Phase III clinical trials of VELCADE based comb...-eligible patients with previously untreated,multi...val (PFS) was observed,in one study comparing VELC...mycin and dexamethasone (VAD), as well as in anoth...
...sts that ofatumumab has activity in heavily pre-tr... , , , PHILADELPHIA, Dec. 8 GlaxoSmithKli... positive results from a pivotal trial pre-planned...he treatment of refractory chronic lymphocytic leu... of ofatumumab for heavily pre-treated patients wi...
Other Medicine Technology:Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 2Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 3Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 4Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 5Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 6Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 7Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 2Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 3Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 4Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 5Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 6Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 7Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 8Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 9
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products: